Previous Article | Next Article 
Infection and Immunity, September 1998, p. 4087-4092, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Biphasic mRNA Expression Pattern of Bovine Interleukin-8 in
Pasteurella haemolytica Lipopolysaccharide-Stimulated
Alveolar Macrophages Is Primarily due to Tumor Necrosis
Factor Alpha
Rhonda L.
Lafleur,
Mitchell
S.
Abrahamsen, and
Samuel K.
Maheswaran*
Department of Veterinary PathoBiology,
College of Veterinary Medicine, University of Minnesota, St. Paul,
Minnesota 55108
Received 22 December 1997/Returned for modification 20 February
1998/Accepted 20 May 1998
 |
ABSTRACT |
Pasteurella haemolytica serotype 1 is the bacterial
agent responsible for the pathophysiological events associated
with bovine pneumonic pasteurellosis. Our previous studies support a
role for the lipopolysaccharide (LPS) from P. haemolytica in the induction of proinflammatory cytokines. One of
the pathological hallmarks of bovine pneumonic pasteurellosis is an
influx of neutrophils into the alveolar spaces. This pronounced influx
suggests the local production of a chemotactic factor(s) such as
interleukin-8 (IL-8). In the context of the lung, the alveolar
macrophage appears to be the major producer of IL-8, a proinflammatory
cytokine with potent neutrophil chemotactic activity. By using Northern
blot analysis, we have examined the kinetics of IL-8 mRNA
expression in P. haemolytica LPS-stimulated bovine
alveolar macrophages and found that 1 ng of LPS per ml induces maximal
expression of IL-8 mRNA. The results also indicate a biphasic time
course expression pattern in which IL-8 mRNA levels peak between 1 and 2 h in the first phase and between 16 and 24 h in the
second phase (P < 0.01). In addition, monospecific
polyclonal antibodies were used to demonstrate the role of tumor
necrosis factor alpha (TNF-
) in the second phase of IL-8 mRNA
expression. Our findings support a role for P. haemolytica LPS and TNF-
in the induction of IL-8 from bovine alveolar macrophages.
 |
INTRODUCTION |
Economic losses from bovine
pneumonic pasteurellosis, commonly known as shipping
fever, cost the cattle industry billions of dollars annually
(1). Although shipping fever is a multifactorial disease
involving infection by a variety of microorganisms in conjunction with
stressful management practices and environmental factors,
Pasteurella haemolytica serotype 1 is the primary agent responsible for the clinical disease and pathophysiologic events (17, 32). Bovine pneumonic pasteurellosis is an acute
fibrinonecrotizing pleuropneumonia characterized by an influx of
neutrophils into the alveoli; accumulation of fibrinous edema fluid
within the alveoli, pleural surface, and interlobular septa;
hemorrhage; vascular thrombosis; and coagulative parenchymal necrosis
of the lung (31). A substantial amount of evidence
implicates the neutrophil in the pathogenesis of lung injury in bovine
pneumonic pasteurellosis (19, 28, 30). Studies involving a
calf model of experimental pneumonic pasteurellosis have shown that
marked neutrophil influx into the alveoli occurs within the first few
hours after bacterial inoculation and that peracute lung lesions are
evident within the first 6 h postinfection (19, 28). In
these studies, neutrophil depletion ameliorated the lung injury and the
pathophysiologic alterations that occur in the intact animal
(19). These findings imply that neutrophils are the primary
effector cells of the peracute lung injury associated with the disease.
The influx of neutrophils into the alveolar space early in the disease
suggests the generation of specific chemotactic factors which promote
neutrophil recruitment into the alveolar compartment.
Pasteurella haemolytica possesses several virulence factors,
of which the lipopolysaccharide (LPS) and leukotoxin (Lkt) appear to be
the most important. P. haemolytica LPS is similar to
LPS produced by other gram-negative bacteria and is composed of
biologically active lipid A, core oligosaccharide, and an
antigenic polysaccharide side chain (O antigen) (4). We have
shown that purified LPS from P. haemolytica A1
given intrabronchially causes neutrophil and platelet influx, fibrin
exudation, and edema in the alveolar spaces, neutrophil aggregation in
the capillaries, and other pathophysiological derangements in the lungs
(30). More recently, we reported that purified LPS
from P. haemolytica induced tumor necrosis factor alpha (TNF-
) and interleukin-1
(IL-1
) mRNA
expression in bovine alveolar macrophages (AMs) and secretion of
these biologically active cytokines (33).
TNF-
is a proinflammatory cytokine hypothesized to be involved in
the inflammatory cascade caused by P. haemolytica.
TNF-
has a profound effect on tissue remodeling, repair, and
inflammation by coordinating the activities of many other cells,
including endothelial cells, granulocytes, fibroblasts, and lymphoid
cells (12). Although not directly chemotactic, TNF-
facilitates leukocyte recruitment by upregulating leukocyte adhesion
proteins on endothelial cells (9), as well as through the
paracrine induction of leukocyte chemotactic factor synthesis
from immune (22) and nonimmune (20, 23-25)
cells of the lung.
IL-8 is a CXC chemokine that is produced by many cell types, including
monocytes/macrophages, fibroblasts, epithelial cells, endothelial
cells, and neutrophils (2). Although IL-8 has been shown to
have chemotactic activity for T lymphocytes, eosinophils, and
basophils, it is the most potent chemoattractant for neutrophils. In
addition, IL-8 is able to induce many neutrophil activities including
oxidative burst, exocytosis of specific granules, and release of
proteases (16, 27).
We hypothesize that the initial interaction of P. haemolytica LPS with resident AMs leads to the production and
release of TNF-
and IL-8, along with other proinflammatory
molecules, into the alveolar spaces. This is followed by recruitment
of neutrophils, eruption of a cytokine-mediated inflammatory
cascade, and neutrophil activation, resulting in the release of toxic
oxygen radicals, proteases, and cytokines which participate in direct
lung tissue injury. The focus of this study is to characterize the
expression of IL-8 mRNA from bovine AMs stimulated with purified
LPS from P. haemolytica A1.
 |
MATERIALS AND METHODS |
Antibodies and reagents.
Monospecific polyclonal antibodies
against recombinant bovine TNF-
produced in rabbit (anti-bovine
TNF-
) and preimmune rabbit serum were both generously provided by
T. H. Elsasser, U.S. Department of Agriculture, Beltsville, Md.
LPS from P. haemolytica 12296 was isolated by the
hot-phenol-water extraction technique as described previously
(29, 33). The concentration of endotoxin present in the LPS,
as determined by the Limulus amebocyte lysate assay (BioWhittaker, Walkersville, Md.), revealed that 1 µg of LPS per ml
was equivalent to approximately 150 endotoxin units. Recombinant human
TNF-
(rhTNF-
) was purchased from PharMingen (San Diego, Calif.)
and contained less than 0.1 ng of LPS/µg of human TNF-
.
Bacterial strains, plasmids, and media.
Escherichia
coli DH5
competent cells were obtained from Gibco BRL (Grand
Island, N.Y.), pGEM3zf(+) was purchased from Promega (Madison, Wis.),
and pET15b was purchased from Novagen (Madison, Wis.). E. coli DH5
transformed with recombinant pGEM3zf(+) was grown in
Luria-Bertani medium containing 50 µg of ampicillin per ml.
Recovery and isolation of AMs.
AMs were collected by lung
lavage with sterile, endotoxin-free phosphate-buffered saline (pH 7.4)
from healthy, 3- to 6-week-old calves sedated with an intravenous
injection of xylazine hydrochloride (Miles Inc., Shawnee Mission,
Kan.). Approximately 107 cells in Dulbecco's modified
Eagle's medium (Celox, Oakdale, Minn.) (supplemented with 2% fetal
bovine serum, 1 mM L-glutamine, 0.1 mM nonessential amino
acids, 14 mM HEPES, 100 U of penicillin per ml, 0.1 mg of streptomycin
per ml, and 25 µg of amphotericin B per ml in 0.9% sodium chloride)
were plated onto 10-cm tissue culture petri dishes and allowed to
adhere for 3 h at 37°C in a humidified atmosphere containing 5%
CO2. Nonadherent cells were removed, and adherent AMs were
incubated with fresh medium for at least 36 h. Adherent
populations were >95% macrophages and >98% viable as determined by
nonspecific esterase staining and trypan blue dye exclusion,
respectively. Following incubation, inducers or treatments were added
directly to the existing media.
Stimulation of AMs.
When stimulating AMs, the cells were
cultured in the presence of either purified LPS from P. haemolytica 12296 or rhTNF-
. Concentrations of LPS or rhTNF-
and exposure times varied as described for individual experiments. In
the experiments with polymyxin B (Sigma Chemical Co., St. Louis, Mo.),
10 µg of polymyxin B per ml was preincubated with 1 µg of LPS per
ml for 30 min before AM stimulation. When the anti-bovine TNF-
antibodies and the preimmune rabbit serum were used, different
dilutions were preincubated with 1 µg of LPS per ml for 30 min before
AM stimulation. Supernatants were collected by centrifugation at
1,000 × g for 10 min, aliquoted, and frozen at
70°C.
Cloning of bovine IL-8 cDNA.
Total RNA was extracted from
AMs by the guanidinium isothiocyanate-phenol-chloroform procedure
(3). The concentration of RNA was determined by measuring
the absorbance at 260 nm with a spectrophotometer. Contaminating DNA
was removed from the total RNA with RNase-free DNase I by incubation at
37°C for 15 min. By using 2 µl of random hexamer primers (Perkin
Elmer, Foster City, Calif.), RNA was reverse transcribed at 42°C for
1 h in a final volume of 20 µl. PCR was performed for 30 cycles
(93°C for 1 min, 50°C for 30 s, and 72°C for 30 s) with
the synthesized single-stranded cDNA and the following primers based on
conserved IL-8 sequence from pig, human, and rabbit:
5'CTCT(CG)TGTGA(GA)GCTGCAGTTCTG-3' and
5'-T(TG)CTCAG(TC)(TC)CTCTTCAA(AG)AA(TC)AT-3'. The
amplified product was ligated into the pGEM3zf(+) vector and sequenced
by the dideoxy chain termination method (26). The remaining
sequence at the 3' end was acquired through the use of 3' RACE (rapid
amplification of cDNA ends) (Gibco BRL, Gaithersburg, Md.), and the
entire mature protein sequence was cloned into the pET15b expression
vector.
Northern blot analysis.
Approximately 5 µg of RNA from
each sample was electrophoresed on 1.2% formaldehyde-agarose gels and
transferred to nitrocellulose membranes. Hybridization was performed at
45°C with either [
-32P]dCTP (Amersham, Arlington
Heights, Ill.)-labeled bovine IL-8 cDNA insert or
[
-32P]dCTP-labeled bovine TNF-
cDNA insert
(33) at 1 × 106 to 2 × 106 cpm/ml for at least 4 h in a solution containing
50% deionized formamide, 30% 20× SSC (1× SSC is 0.15 M NaCl plus
0.015 M sodium citrate), 4% 50X Denhardt's solution, 5% 1 M
NaH2PO4 (pH 7.0), 4 mg of yeast tRNA per ml,
and 10% dextran. The membranes were washed and exposed to X-ray film
(Kodak) with an intensifying screen for 4 to 48 h at
80°C. All
blots were rehybridized with a human
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe as an
internal control to normalize the signal between samples. To quantify
relative levels of hybridization signal, membranes were placed in a
phosphorimaging cassette and analyzed with phosphorimaging software
(Molecular Dynamics, Sunnyvale, Calif.).
The results are expressed as a percentage of the band representing the
maximal intensity for each blot. Values are presented as means ± standard errors of the mean (SEM). Data were analyzed by a two-tailed
t test, and statistical significance was set at P < 0.01.
TNF-
bioassay.
TNF-
was measured by a bioassay
(8) with WEHI-13VAR cells, a variant of WEHI 164 clone 13. The cells were plated on 96-well plates at 3.5 × 104
cells per well in RPMI 1640 medium (BioWhittaker) containing 5% fetal
bovine serum. The plates were incubated at 37°C overnight in a
humidified atmosphere containing 5% CO2. The medium was
removed the following morning, and 50 µl of a 1-µg/ml actinomycin D
(Sigma) solution was added to each well. Samples containing either
rhTNF-
(positive control), medium plus 5% fetal bovine serum
(negative control), or macrophage supernatants were used in duplicate
(100 µl/well) and incubated as above. At 24 h later, 25 µl of
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT;
Sigma) dissolved in phosphate-buffered saline at 5 mg/ml was added to
each well. The plates were allowed to incubate for an additional 3 h at 37°C, and then 100 µl of 50% dimethyl formamide-20% sodium
dodecyl sulfate (pH 4.7) (10) was added per well. After
1 h, the optical density at 570 nm was measured with a microplate
enzyme-linked immunosorbent assay reader (Molecular Device Corp., Menlo
Park, Calif.). Concentrations of TNF-
were expressed in picograms
per milliliter, which were extrapolated based on a standard curve
established with rhTNF-
. The results of the bioassay are expressed
as means ± SEM.
 |
RESULTS |
Cloning of bovine IL-8 cDNA.
Through the use of primer
sequences based on IL-8 cDNA sequence data from human, pig, and rabbit,
a 230-bp cDNA fragment encoding the first 77 amino acids of the bovine
IL-8 mature protein was amplified by PCR. The amplified fragment was
purified, ligated into pGEM3zf(+), and then transformed into E. coli DH5
. The remaining sequence at the 3' end of the coding
region was obtained by 3' RACE. After subcloning into the pET15b
expression vector and sequence analysis, the entire mature protein cDNA
sequence of 84 amino acids was found to be identical to bovine IL-8
sequence data published after these studies were initiated
(15).
Kinetics of IL-8 mRNA expression in bovine AMs stimulated
with P. haemolytica LPS.
Preliminary experiments
revealed that IL-8 mRNA was induced during the isolation of bovine
AMs. Therefore, before any induction experiments could be performed, it
was important to establish the duration of culture that bovine AMs
required to reach undetectable levels of IL-8 mRNA. AMs were
plated, allowed to adhere for 3 h, washed, and then harvested at
4, 8, 16, 24, and 36 h. As shown in Fig.
1, IL-8 mRNA levels were undetectable
by Northern blot analysis at 24 h. Since the exact culture time
needed to reach undetectable levels of IL-8 mRNA was somewhat
variable, the cells were allowed to incubate for at least 36 h in
all subsequent experiments.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Length of time required by bovine AMs to become
quiescent for bovine IL-8 mRNA. (A) Northern blot analysis with the
IL-8 probe was performed as described in Materials and Methods. (B)
Relative levels of hybridization signal were normalized to GAPDH. The
data shown are representative of two separate experiments.
|
|
Bovine AMs were stimulated with various concentrations (0.001 to 1,000 ng/ml) of
P. haemolytica LPS for 1 h. As shown by
Northern
blot analysis (Fig.
2),
P. haemolytica LPS induced bovine AMs
to express IL-8
mRNA. Expression steadily increased to a peak
at 1 ng/ml and then
decreased slightly to a level that remained
constant with increasing
concentrations of LPS. This induced expression
was entirely due to LPS,
since preincubation of LPS with polymyxin
B completely abrogated any
expression of IL-8 mRNA (Fig.
3).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Bovine IL-8 mRNA expression in bovine AMs stimulated
with various concentrations of P. haemolytica LPS for
1 h. (A) Northern blot analysis with the IL-8 probe was performed
as described in Materials and Methods. (B) Relative levels of IL-8
mRNA were normalized to GAPDH mRNA levels. The data shown are
representative of three separate experiments.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of polymyxin B (PMB) on bovine IL-8 mRNA
expression. Bovine AMs were cultured in the presence of 1 µg of
P. haemolytica LPS per ml with or without preincubation
of 10 µg of polymyxin B per ml. (A) After 1 h, the cells were
harvested and Northern blot analysis was performed as described in
Materials and Methods. (B) Relative levels of IL-8 mRNA were
normalized to GAPDH. The data shown are representative of three
separate experiments.
|
|
To determine the kinetics of IL-8 mRNA expression, bovine AMs were
harvested at various times following stimulation with 1
µg of
P. haemolytica LPS per ml. This concentration was used
in
the following experiments since it had been shown to induce maximal
expression of bovine TNF-

mRNA in AMs (
33). In
related studies,
1 µg of LPS from
E. coli per ml was used
to stimulate human whole
blood, which resulted in a similar IL-8
mRNA expression pattern
to the one described below (
5,
7). As shown by Northern
blot analysis (Fig.
4; also see Fig.
8), LPS-stimulated AMs
expressed
IL-8 mRNA in a biphasic pattern. Although the relative
amount
of IL-8 mRNA expressed at specific time points is somewhat
variable
among experiments, the biphasic pattern of expression is
statistically
significant (
P < 0.01), as demonstrated
in Fig.
4C. IL-8 mRNA
levels increased to a peak between 1 and
2 h, decreased to baseline
levels at 4 h, and peaked again
between 16 and 24 h (Fig.
4A).
The higher level of IL-8 expression
at 1 h in Fig.
8 compared
to Fig.
4 is most probably due to the
increased amount of IL-8
mRNA in the unstimulated cells. Results
also indicated that maximal
mRNA expression in the second phase was
approximately 10 times
greater than that in the first phase. This
biphasic pattern suggests
that the first phase is mediated by the
initial LPS stimulation
whereas the second phase results from
stimulation by a macrophage-derived
molecule produced in response to
the initial LPS stimulation.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
Time course of bovine IL-8 mRNA expression. Bovine
AMs were stimulated with 1 µg of P. haemolytica LPS
per ml for the indicated times. (A) Northern blot analysis with the
IL-8 probe was performed as described in Materials and Methods. (B)
Relative levels of hybridization signal were normalized to GAPDH. The
data shown are representative of three separate experiments. (C) The
results are expressed as a percentage of the band representing the
maximal intensity for each blot. The final results represent mean ± SEM (n = 3).
|
|
rhTNF-
induces expression of bovine IL-8 mRNA in bovine
AMs.
Previous studies with LPS-stimulated human whole blood have
also shown a biphasic pattern for IL-8 mRNA and protein (5, 7). It was found that the second phase was in part the result of
stimulation by TNF-
(5). To address the role of TNF-
in the second phase of IL-8 mRNA induction, bovine AMs were
stimulated with 2 and 20 ng of rhTNF-
per ml for 4 h. As shown
by Northern blot analysis (Fig. 5),
rhTNF-
induced IL-8 mRNA in a dose-dependent manner. To
demonstrate that rhTNF-
-induced IL-8 mRNA expression was not due
to the small amount of contaminating LPS found in recombinant proteins
produced by E. coli, rhTNF-
was either boiled or
preincubated with polymyxin B prior to AM stimulation. IL-8 mRNA
was not induced when 20 ng of rhTNF-
per ml was boiled for 30 min
(Fig. 5, lane 20-HIA), and preincubation of 20 ng of rhTNF-
per ml
with 10 µg of polymyxin B per ml for 30 min had no effect on the
level of induction compared to the results obtained with 20 ng of
rhTNF-
per ml alone (lane 20-PMB).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 5.
IL-8 mRNA expression is induced by recombinant human
TNF- . (A) After 4 h, the cells were harvested and Northern blot
analysis was performed as described in Materials and Methods. HIA, 20 ng of rhTNF- per ml was boiled for 30 min before being added to AMs.
(B) Relative levels of IL-8 mRNA were normalized to GAPDH. The data
shown are representative of two separate experiments.
|
|
P. haemolytica LPS-stimulated AMs express bovine
TNF-
mRNA and secrete bioactive TNF-
protein.
To
demonstrate the ability of LPS to induce TNF-
mRNA, blots from
LPS-stimulated time course experiments were rehybridized with a bovine
TNF-
probe. As shown by Northern blot analysis (Fig.
6), 1 µg of LPS per ml induced TNF-
mRNA expression in bovine AMs. The kinetics of TNF-
mRNA
expression were quite different from those of IL-8 expression, since a
peak in mRNA at 1 h was followed by a steady decline over
time. These results are consistent with those previously published by
Yoo et al. (33).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 6.
Time course of bovine TNF- mRNA expression.
Bovine AMs were stimulated with 1 µg of P. haemolytica LPS per ml for the indicated times. Northern blot
analysis with the bovine TNF- probe was performed as described in
Materials and Methods.
|
|
To determine the kinetics of TNF-

protein secretion from AMs,
macrophage supernatants which had been aliquoted and frozen
from
LPS-stimulated time course experiments were assayed for bioactive
TNF-

. As demonstrated in Fig.
7,
1
µg of
P. haemolytica LPS per
ml stimulated bovine AMs
to secrete bioactive TNF-

. After 8 h
of LPS stimulation, the
amount of TNF-

increased to approximately
700 pg/ml.

View larger version (7K):
[in this window]
[in a new window]
|
FIG. 7.
Time-dependent secretion of extracellular TNF- by
bovine AMs stimulated with 1 µg of P. haemolytica LPS
per ml for the indicated times, as assessed by a bioassay. The TNF-
concentration was calculated by using the mean absorbance of duplicate
wells and is expressed in picograms per milliliter as described in
Materials and Methods. The values shown represent mean ± SEM
(n = 3).
|
|
Antibodies against bovine TNF-
reduced IL-8 mRNA in the
second phase of expression.
To further demonstrate the role of
TNF-
in the second phase of IL-8 mRNA induction, various
dilutions of monospecific polyclonal antibodies against bovine TNF-
were preincubated with 1 µg of P. haemolytica LPS per
ml for 30 min before macrophage stimulation. AMs were harvested at 0, 1, 4, and 24 h after stimulation. As shown by Northern blot
analysis (Fig. 8), an antibody dilution of 1:1,000 significantly reduced IL-8 mRNA levels at 24 h
compared to the results obtained with LPS alone. As a control, the same dilution of preimmune serum was preincubated with 1 µg of LPS per ml,
and as expected, the preimmune serum did not reduce IL-8 mRNA
levels at any time point.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 8.
Inhibition of bovine IL-8 mRNA expression with
monospecific polyclonal antibodies against bovine TNF- . (A) Northern
blot analysis with the IL-8 probe was performed as described in
Materials and Methods. (B) Relative levels of IL-8 mRNA were
normalized to GAPDH mRNA levels. The data shown are representative
of two separate experiments. PIS, preimmune serum.
|
|
 |
DISCUSSION |
One of the pathological hallmarks of bovine pneumonic
pasteurellosis is an influx of neutrophils into the alveolar spaces. Although no definitive evidence has been presented about which factor(s) is responsible for the recruitment of neutrophils into the alveolar milieu, the influx is thought to be mediated by a locally
produced chemotactic factor(s). IL-8 is a potent neutrophil chemotactic
factor involved in the pathology of several inflammatory diseases
including psoriasis (18) and adult respiratory distress syndrome (11). In the context of the lungs, there is
compelling evidence which suggests that the AM is the major source of
IL-8. Since bovine IL-8 had not been cloned at the start of this
project, we designed primers based on IL-8 cDNA sequences from other
species and used PCR and 3' RACE to amplify the entire mature protein cDNA coding region. Sequence analysis revealed that this clone was
identical to one used in a recently published experiment
(15).
Since the AM seems to be the central cell in orchestrating the
inflammatory response against P. haemolytica infection,
we investigated the kinetics of IL-8 mRNA expression in
P. haemolytica LPS-stimulated AMs. Our preliminary
studies revealed that when bovine AMs were incubated only
overnight, IL-8 mRNA levels in unstimulated cells were nearly
or as high as levels in LPS-stimulated cells. We hypothesize that this
level of expression was residual mRNA that had been induced
during the isolation and plating of cells (21). To quantify
the amount of mRNA induction in stimulated cells with respect
to that in unstimulated cells, IL-8 mRNA expression needed to start at a basal level. In unstimulated cells,
undetectable levels of IL-8 mRNA were consistently reached only
when AMs were allowed to rest for at least 36 h.
Our in vitro experiments have shown that bovine IL-8 is abundantly
expressed in AMs stimulated with P. haemolytica LPS and TNF-
. mRNA was elevated above resting levels with as little as 10 pg of LPS per ml, and maximum induction was seen at 1 ng/ml. Northern blot analysis also revealed that AMs stimulated with 1 µg of
LPS per ml over a 24-h period expressed IL-8 mRNA in a biphasic
expression pattern. This observation is consistent with a role for IL-8
in the initial recruitment of neutrophils into the alveolar space and
in the subsequent neutrophil activation which can lead to tissue
damage. Although many other laboratories have studied IL-8
mRNA expression in LPS-stimulated AMs, our findings of a biphasic
expression pattern have put us in an exclusive group. Similar results
have been documented only in studies of IL-8 mRNA and protein in
human whole blood stimulated with LPS from E. coli (5,
7). A biphasic expression pattern for IL-8 has not been demonstrated in LPS-stimulated AMs from other species including pigs,
sheep, and dogs (13). In support of our results, we
have shown IL-8 mRNA levels at 0 and 4 h to be significantly
different from those at 1 and 24 h (P < 0.01).
TNF-
has been implicated as a primary mediator of the inflammatory
response, with a characteristic rapid burst of production initiating
the release of a cascade of other mediators (6). One key
function of this early mediator may be the induction of IL-8 release,
which can attract neutrophils to tissue sites of inflammation
(14). TNF-
has been shown to induce the expression of
IL-8 in several cell types, including fibroblasts and epithelial cells,
which are nonresponsive to direct LPS stimulation (2, 14).
DeForge et al. have shown that a mixture of anti-TNF, anti-IL-1
, and
anti-IL-1
antibodies could nearly completely ablate the secondary wave of IL-8 mRNA expression and protein secretion (5).
We have demonstrated the induction of TNF-
mRNA and protein
secretion from LPS-stimulated AMs and the induction of IL-8 mRNA in
rhTNF-
-stimulated AMs. Using polyclonal antibodies against bovine
TNF-
, we have also demonstrated a substantial decrease in the IL-8
mRNA level at 24 h. Although the initial phase of IL-8
mRNA expression was not altered by antibodies against bovine
TNF-
, the levels in the prolonged, secondary phase were
significantly reduced in the presence of antibody. We hypothesize that
the remaining mRNA may be due to other inflammatory mediators such
as IL-1
and IL-1
(5). These results provide evidence
that the first phase of IL-8 mRNA expression from AMs is an
LPS-mediated event whereas the second phase is due to the early,
LPS-stimulated release of mediators such as TNF-
, which act in an
autocrine or paracrine fashion on other AMs.
Taken together, these results suggest that inflammatory cytokines such
as IL-8 may play an important role in the pathogenesis of lung injury
seen in bovine pneumonic pasteurellosis. Our results also emphasize the
complex network of cytokines in an inflammatory response. Because a
pronounced influx of neutrophils into the alveolar spaces occurs in
many pulmonary diseases including bovine pneumonic pasteurellosis,
further experiments are needed to explore the direct role of IL-8 in
the recruitment of neutrophils into the lung.
 |
ACKNOWLEDGMENTS |
We thank Christie Malazdrewich for her help in collecting the
alveolar macrophages, and Elaina Bleifield for her assistance with the
TNF-
bioassay, and Shih-Ling Hsuan for providing purified LPS from
P. haemolytica.
This study was supported by USDA-NRI competitive grant 95-37204-1963 (to S.K.M.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Veterinary PathoBiology, University of Minnesota, 1971 Commonwealth
Ave., St. Paul, MN 55108. Phone: (612) 625-6264. Fax: (612) 624-4785. E-mail: mahes001{at}maroon.tc.umn.edu.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Babiuk, L. A.,
M. J. P. Lawman,
M. I. Biol, and G. A. Gifford.
1987.
Bovine respiratory disease: pathogenesis and control by interferon, p. 12-24.
In
A seminar in bovine immunology. Western Veterinary Conference. Veterinary Learning Systems Co., Inc., Las Vegas, Nev.
|
| 2.
|
Baggiolini, M.,
A. Walz, and S. L. Kunkel.
1989.
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
J. Clin. Invest.
84:1045-1049.
|
| 3.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 4.
|
Confer, A. W.,
R. J. Panciera,
K. D. Clinkenbeard, and D. A. Mosier.
1990.
Molecular aspects of virulence of Pasteurella haemolytica.
Can. J. Vet. Res.
54:S48-S52.
|
| 5.
|
DeForge, L. E.,
J. S. Kenney,
M. L. Jones,
J. S. Warren, and D. G. Remick.
1992.
Biphasic production of IL-8 in lipolysaccharide (LPS)-stimulated human whole blood.
J. Immunol.
148:2133-2141[Abstract].
|
| 6.
|
DeForge, L. E.,
D. T. Nguyen,
S. L. Kunkel, and D. G. Remick.
1990.
Regulation of the pathophysiology of tumor necrosis factor.
J. Lab. Clin. Med.
116:429-438[Medline].
|
| 7.
|
DeForge, L. E., and D. G. Remick.
1991.
Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood.
Biochem. Biophys. Res. Commun.
174:18-24[Medline].
|
| 8.
|
Ellis, J. A.,
D. Godson,
M. Campos,
M. Sileghem, and L. A. Babiuk.
1993.
Capture immunoassay for ruminant tumor necrosis factor- : comparison with bioassay.
Vet. Immunol. Immunopathol.
35:289-300[Medline].
|
| 9.
|
Gamble, J. R.,
J. M. Harlan,
S. J. Klebanoff, and M. A. Vadas.
1985.
Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.
Proc. Natl. Acad. Sci. USA
82:8667-8671[Abstract/Free Full Text].
|
| 10.
|
Hansen, M. B.,
S. E. Nielsen, and K. Berg.
1989.
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.
J. Immunol. Methods
119:203-210[Medline].
|
| 11.
|
Jorens, P. G.,
J. Van Damme,
W. DeBacker,
L. Bossaert,
R. F. DeJongh,
A. G. Herman, and M. Rampart.
1992.
Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS.
Cytokine
4:592-597[Medline].
|
| 12.
|
Larrick, J. W., and S. L. Kunkel.
1988.
The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.
Pharm. Res.
5:129-138[Medline].
|
| 13.
|
Lin, G.,
A. E. Pearson,
R. W. Scamurra,
Y. Zhou,
M. J. Baarsch,
D. J. Weiss, and M. P. Murtaugh.
1994.
Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial lipopolysaccharide.
J. Biol. Chem.
269:77-85[Abstract/Free Full Text].
|
| 14.
|
Matsushima, K., and J. J. Oppenheim.
1989.
Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF.
Cytokine
1:2-13[Medline].
|
| 15.
|
Morsey, M. A.,
Y. Popowych,
J. Kowalski,
G. Gerlach,
D. Godson,
M. Campos, and L. A. Babiuk.
1996.
Molecular cloning and expression of bovine interleukin-8.
Microb. Pathog.
20:203-212[Medline].
|
| 16.
|
Peveri, P.,
A. Walz,
B. Dewald, and M. Baggiolini.
1988.
A novel neutrophil-activating factor produced by human mononuclear phagocytes.
J. Exp. Med.
167:1547-1559[Abstract/Free Full Text].
|
| 17.
|
Rehmtulla, A. J., and R. G. Thomson.
1981.
A review of the lesions of shipping fever of cattle.
Can. Vet. J.
22:1-8[Medline].
|
| 18.
|
Schroeder, J. M., and E. Christophers.
1986.
Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales.
J. Invest. Dermatol.
87:53-58[Medline].
|
| 19.
|
Slocombe, R. F.,
J. Malark,
R. Ingersoll,
F. J. Derksen, and N. E. Robinson.
1985.
Importance of neutrophils in the pathogenesis of acute pneumonic pasteurellosis in calves.
Am. J. Vet. Res.
46:2253-2258[Medline].
|
| 20.
|
Standiford, T. J.,
S. L. Kunkel,
M. A. Basha,
S. W. Chensue,
J. P. Lynch III,
G. B. Toews,
J. Westwick, and R. M. Strieter.
1990.
Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung.
J. Clin. Invest.
86:1945-1953.
|
| 21.
|
Standiford, T. J.,
S. L. Kunkel,
K. Kasahara,
M. J. Milia,
M. W. Rolfe, and R. M. Strieter.
1991.
Interleukin-8 gene expression from human alveolar macrophages: the role of adherence.
Am. J. Respir. Cell Mol. Biol.
5:579-585.
|
| 22.
|
Strieter, R. M.,
S. W. Chensue,
M. A. Basha,
T. J. Standiford,
J. P. Lynch,
M. Baggiolini, and S. L. Kunkel.
1990.
Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta.
Am. J. Respir. Cell Mol. Biol.
2:3221-3226.
|
| 23.
|
Strieter, R. M.,
S. L. Kunkel,
H. J. Showell,
D. G. Remick,
S. H. Phan,
P. A. Ward, and R. M. Marks.
1989.
Endothelial cell gene expression of a neutrophil chemotactic factor by TNF- , LPS, and IL-1 .
Science
243:1467-1469[Abstract/Free Full Text].
|
| 24.
|
Strieter, R. M.,
S. H. Phan,
H. J. Showell,
D. G. Remick,
J. P. Lynch,
M. Genord,
C. Raiford,
M. Eskandari,
R. M. Marks, and S. L. Kunkel.
1989.
Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts.
J. Biol. Chem.
264:10621-10626[Abstract/Free Full Text].
|
| 25.
|
Strieter, R. M.,
R. Wiggins,
S. H. Phan,
B. L. Wharram,
H. J. Showell,
D. G. Remick,
S. W. Chensue, and S. L. Kunkel.
1989.
Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells.
Biochem. Biophys. Res. Commun.
162:694-700[Medline].
|
| 26.
|
Tabor, S., and C. C. Richardson.
1987.
DNA sequence analysis with a modified bacteriophage T7 polymerase.
Proc. Natl. Acad. Sci. USA
84:4767-4771[Abstract/Free Full Text].
|
| 27.
|
Thelen, M.,
P. Peveri,
P. Keren,
V. Von Tscharner,
A. Walz, and M. Baggiolini.
1988.
Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide agonist.
FASEB J.
2:2702-2706[Abstract].
|
| 28.
|
Walker, R. D.,
F. M. Hopkins,
T. W. Schultz,
M. D. McCracken, and R. N. Moore.
1985.
Changes in leukocyte populations in pulmonary lavage fluids of calves after inhalation of Pasteurella haemolytica.
Am. J. Vet. Res.
46:2429-2433[Medline].
|
| 29.
|
Westphal, O., and K. Jann.
1965.
Bacterial lipopolysaccharide: extraction with phenol-water and further applications of the procedure.
Methods Carbohydr. Chem.
5:83-91.
|
| 30.
|
Whiteley, L. O.,
S. K. Maheswaran,
D. J. Weiss, and T. R. Ames.
1991.
Alterations in pulmonary morphology and peripheral coagulation profiles caused by intratracheal inoculation of live and ultraviolet light-killed Pasteurella haemolytica A1 in calves.
Vet. Pathol.
28:275-285[Abstract].
|
| 31.
|
Whiteley, L. O.,
S. K. Maheswaran,
D. J. Weiss,
T. R. Ames, and M. S. Kannan.
1992.
Pasteurella haemolytica A1 and bovine respiratory disease: pathogenesis.
J. Vet. Intern. Med.
6:11-22[Medline].
|
| 32.
|
Wilke, B. N., and P. E. Shewen.
1988.
Defining the role that Pasteurella haemolytica plays in shipping fever.
Vet. Med.
83:1053-1058.
|
| 33.
|
Yoo, H. S.,
S. K. Maheswaran,
G. Lin,
E. L. Townsend, and T. R. Ames.
1995.
Induction of inflammatory cytokines in bovine alveolar macrophages following stimulation with Pasteurella haemolytica lipopolysaccharide.
Infect. Immun.
63:381-388[Abstract].
|
Infection and Immunity, September 1998, p. 4087-4092, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sugimoto, M., Fujikawa, A., Womack, J. E., Sugimoto, Y.
(2006). Evidence that bovine forebrain embryonic zinc finger-like gene influences immune response associated with mastitis resistance. Proc. Natl. Acad. Sci. USA
103: 6454-6459
[Abstract]
[Full Text]
-
Starr, A. E., Dan, T., Minhas, K., Shewen, P. E., Coomber, B. L.
(2004). Potential Involvement of Gelatinases and Their Inhibitors in Mannheimia haemolytica Pneumonia in Cattle. Infect. Immun.
72: 4393-4400
[Abstract]
[Full Text]
-
Booth, J. L., Coggeshall, K. M., Gordon, B. E., Metcalf, J. P.
(2004). Adenovirus Type 7 Induces Interleukin-8 in a Lung Slice Model and Requires Activation of Erk. J. Virol.
78: 4156-4164
[Abstract]
[Full Text]
-
Kuroishi, T., Komine, K.-i., Asai, K.-i., Kobayashi, J., Watanabe, K., Yamaguchi, T., Kamata, S.-i., Kumagai, K.
(2003). Inflammatory Responses of Bovine Polymorphonuclear Neutrophils Induced by Staphylococcal Enterotoxin C via Stimulation of Mononuclear Cells. CVI
10: 1011-1018
[Abstract]
[Full Text]
-
Serio, K. J., Johns, S. C., Luo, L., Hodulik, C. R., Bigby, T. D.
(2003). Lipopolysaccharide Down-Regulates the Leukotriene C4 Synthase Gene in the Monocyte-Like Cell Line, THP-1. J. Immunol.
170: 2121-2128
[Abstract]
[Full Text]
-
Weiss, D. J., Evanson, O. A., Moritz, A., Deng, M. Q., Abrahamsen, M. S.
(2002). Differential Responses of Bovine Macrophages to Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium. Infect. Immun.
70: 5556-5561
[Abstract]
[Full Text]
-
Leite, F., O'Brien, S., Sylte, M. J., Page, T., Atapattu, D., Czuprynski, C. J.
(2002). Inflammatory Cytokines Enhance the Interaction of Mannheimia haemolytica Leukotoxin with Bovine Peripheral Blood Neutrophils In Vitro. Infect. Immun.
70: 4336-4343
[Abstract]
[Full Text]
-
Malazdrewich, C., Ames, T. R., Abrahamsen, M. S., Maheswaran, S. K.
(2001). Pulmonary Expression of Tumor Necrosis Factor Alpha, Interleukin-1 Beta, and Interleukin-8 in the Acute Phase of Bovine Pneumonic Pasteurellosis. Vet Pathol
38: 297-310
[Abstract]
[Full Text]
-
Clemans, D. L., Bauer, R. J., Hanson, J. A., Hobbs, M. V., St. Geme, J. W. III, Marrs, C. F., Gilsdorf, J. R.
(2000). Induction of Proinflammatory Cytokines from Human Respiratory Epithelial Cells after Stimulation by Nontypeable Haemophilus influenzae. Infect. Immun.
68: 4430-4440
[Abstract]
[Full Text]
-
Bortnick, A. E., Rothblat, G. H., Stoudt, G., Hoppe, K. L., Royer, L. J., McNeish, J., Francone, O. L.
(2000). The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines. J. Biol. Chem.
275: 28634-28640
[Abstract]
[Full Text]